Clinical trial
Assessing the Content Validity of a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation
NCT01645371 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Content Validity of a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- February 28, 2013
- Enrollment
- 79 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.